Immune checkpoint inhibitors increase risk of cardiac events

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-88610-5
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 11
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors increase the risk of psoriasis
    Nierengarten, Mary Beth
    CANCER, 2025, 131 (05)
  • [4] The risk of cardiac events in patients receiving immune checkpoint inhibitors a nationwide Danish study
    D'Souza, Maria
    Nielsen, Dorte
    Svane, Inge Marie
    Iversen, Kasper
    Rasmussen, Peter Vibe
    Madelaire, Christian
    Fosbol, Emil
    Kober, Lars
    Gustafsson, Finn
    Andersson, Charlotte
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Schou, Morten
    EUROPEAN HEART JOURNAL, 2021, 42 (16) : 1621 - 1631
  • [6] European Pharmacovigilance Analysis of Cardiac Arrhythmias Events with Immune Checkpoint Inhibitors
    Mascolo, A.
    Sportiello, L.
    Rafaniello, C.
    Scisciola, L.
    Barbieri, M.
    Rossi, F.
    Paolisso, G.
    Capuano, A.
    DRUG SAFETY, 2022, 45 (10) : 1115 - 1116
  • [7] Risk factors for immune mediated adverse events with immune checkpoint inhibitors.
    Pelcovits, Ari
    Mistry, Hetal
    Chudasama, Rani
    Andrea, Sarah
    Khurshid, Humera
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] A new phenotype of immune related cardiac adverse events induced by immune checkpoint inhibitors
    Fujii, Y. Yuki
    Takei, M.
    Onoguchi, R.
    Endo, A.
    Hirata, N.
    Suzuki, K.
    Hasegawa, T.
    Takahashi, T.
    Nakagawa, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 18 - 18
  • [9] Adverse Events of Immune Checkpoint Inhibitors
    Foller, S.
    Oppel-Heuchel, H.
    Fetter, I.
    Winkler, Y.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (04): : 486 - 491
  • [10] Vaccination and Immune Checkpoint Inhibitors Does Vaccination Increase the Risk of Immune-related Adverse Events? A Systematic Review of Literature
    Desage, Anne-Laure
    Bouleftour, Wafa
    Rivoirard, Romain
    Magne, Nicolas
    Collard, Olivier
    Fournel, Pierre
    Tissot, Claire
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (03): : 109 - 113